Cloning & Mutagenesis Market Size, Share & Trends Analysis Report By Product (Cloning Kits, Mutagenesis Kits, Others), By Technology (Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed Mutagenesis, Others), By End User (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, Diagnostic Laboratories) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 21, 2026 | Author: Dhanashri B | Format: | Report Code: SR8155DR | Pages: 200

Market Segmentation

  1. Cloning & Mutagenesis Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Cloning Kits
    2. Mutagenesis Kits
    3. Others
  2. Cloning & Mutagenesis Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Topo PCR Cloning
    2. Blunt End Cloning
    3. Seamless Cloning
    4. Site-Directed Mutagenesis
    5. Others
  3. Cloning & Mutagenesis Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Biopharmaceutical & Pharmaceutical Companies
    2. CROs & CMOs
    3. Academic & Research Institutes
    4. Diagnostic Laboratories
  4. Regional Cloning & Mutagenesis Market
    1. North America
      1. North America Cloning & Mutagenesis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
      2. North America Cloning & Mutagenesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Topo PCR Cloning
        2. Blunt End Cloning
        3. Seamless Cloning
        4. Site-Directed Mutagenesis
        5. Others
      3. North America Cloning & Mutagenesis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
      4. U.S.
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      5. Canada
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
    2. Europe
      1. Europe Cloning & Mutagenesis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
      2. Europe Cloning & Mutagenesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Topo PCR Cloning
        2. Blunt End Cloning
        3. Seamless Cloning
        4. Site-Directed Mutagenesis
        5. Others
      3. Europe Cloning & Mutagenesis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
      4. U.K.
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      5. Germany
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      6. France
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      7. Spain
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      8. Italy
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      9. Russia
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      10. Nordic
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      11. Benelux
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      12. Rest of Europe
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
    3. APAC
      1. APAC Cloning & Mutagenesis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
      2. APAC Cloning & Mutagenesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Topo PCR Cloning
        2. Blunt End Cloning
        3. Seamless Cloning
        4. Site-Directed Mutagenesis
        5. Others
      3. APAC Cloning & Mutagenesis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
      4. China
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      5. Korea
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      6. Japan
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      7. India
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      8. Australia
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      9. Taiwan
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      10. South East Asia
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      11. Rest of Asia-Pacific
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
    4. Middle East and Africa
      1. Middle East and Africa Cloning & Mutagenesis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
      2. Middle East and Africa Cloning & Mutagenesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Topo PCR Cloning
        2. Blunt End Cloning
        3. Seamless Cloning
        4. Site-Directed Mutagenesis
        5. Others
      3. Middle East and Africa Cloning & Mutagenesis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
      4. UAE
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      5. Turkey
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      6. Saudi Arabia
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      7. South Africa
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      8. Egypt
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      9. Nigeria
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      10. Rest of MEA
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
    5. LATAM
      1. LATAM Cloning & Mutagenesis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
      2. LATAM Cloning & Mutagenesis Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Topo PCR Cloning
        2. Blunt End Cloning
        3. Seamless Cloning
        4. Site-Directed Mutagenesis
        5. Others
      3. LATAM Cloning & Mutagenesis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
        4. Diagnostic Laboratories
      4. Brazil
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      5. Mexico
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      6. Argentina
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      7. Chile
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      8. Colombia
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
      9. Rest of LATAM
        1. Cloning Kits
        2. Mutagenesis Kits
        3. Others
        4. Topo PCR Cloning
        5. Blunt End Cloning
        6. Seamless Cloning
        7. Site-Directed Mutagenesis
        8. Others
        9. Biopharmaceutical & Pharmaceutical Companies
        10. CROs & CMOs
        11. Academic & Research Institutes
        12. Diagnostic Laboratories
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: